RecruitingPsoriasis
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Eligible age
18–70 yrs
Accepts
All genders
Locations
2 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
You may qualify if…
- ✓ Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed consent
- ✓ Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI) score ≥ 12 and a Physician's Global Assessment (PGA) score ≥ 3.
- ✓ Within normal ranges of laboratory assessments
You may not qualify if…
- ✕ Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator
Where it's recruiting
Alabama
Birmingham
California
Chula Vista
Source: ClinicalTrials.gov · NCT07489885 · last updated 2026-06-22